Dogwood Therapeutics Inc (DWTX) Income Statement

Total revenue

--0.00

Revenue

--0.00

Operating expenses

237.11%4.43M

562.68%7.54M

80.58%2.30M

-27.58%1.07M

-15.62%1.31M

-45.54%1.14M

-50.84%1.27M

-59.77%1.48M

-60.69%1.56M

-50.10%2.09M

-36.95%2.59M

-14.29%3.67M

29.56%3.96M

-34.79%4.19M

54.40%4.11M

695.81%4.28M

699.22%3.06M

1035.11%6.42M

261.63%2.66M

8.52%538.38K

0.59%382.55K

--565.73K

--736.33K

--496.13K

--380.31K

R&D expenses

609.01%2.44M

676.33%2.32M

43.01%535.16K

-39.75%336.08K

-30.94%343.72K

-76.54%298.32K

-76.94%374.20K

-76.82%557.84K

-82.03%497.71K

-56.42%1.27M

-45.21%1.62M

-25.01%2.41M

62.22%2.77M

9000.40%2.92M

2639.60%2.96M

13186.97%3.21M

2591.89%1.71M

-89.13%32.07K

-72.49%108.09K

-77.77%24.15K

14.47%63.41K

--295.10K

--392.83K

--108.63K

--55.40K

Depreciation, depletion, and amortization

--17.02K

--12.18K

----

--0.00

----

--0.00

----

Operating profit

-237.11%-4.43M

-562.68%-7.54M

-80.58%-2.30M

27.58%-1.07M

15.62%-1.31M

45.54%-1.14M

50.84%-1.27M

59.77%-1.48M

60.69%-1.56M

50.10%-2.09M

36.95%-2.59M

14.29%-3.67M

-29.56%-3.96M

34.79%-4.19M

-54.40%-4.11M

-695.81%-4.28M

-699.22%-3.06M

-1035.11%-6.42M

-261.63%-2.66M

-8.52%-538.38K

-0.59%-382.55K

---565.73K

---736.33K

---496.13K

---380.31K

Net non-operating interest income (expenses)

Non-operating interest income

----

-47.75%20.49K

-44.95%19.99K

-43.68%22.77K

-22.60%34.95K

136.16%39.22K

655.89%36.31K

4361.70%40.42K

696.19%45.16K

--16.61K

--4.80K

--906.00

--5.67K

----

Non-operating interest expense

----

313.95%329.40K

----

9.22%79.58K

38.35%104.44K

62.00%116.20K

11.93%84.00K

--72.86K

--75.49K

--71.73K

--75.05K

Gains from sale of securities

---23.27K

---30.79K

----

Special income (expenses)

---6.13M

----

Other non-operating income (expenses)

----

--0.00

--43.22K

----

--0.00

----

Income before tax

-731.26%-10.73M

-600.56%-7.73M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

-554.30%-4.28M

-555.02%-3.06M

-918.06%-6.50M

-235.55%-2.72M

-15.27%-654.59K

-2.46%-466.55K

---638.59K

---811.82K

---567.86K

---455.36K

Income tax

--190.54K

---503.00

----

--0.00

----

--0.00

Income after tax

-746.02%-10.92M

-600.51%-7.73M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

-554.30%-4.28M

-555.02%-3.06M

-918.06%-6.50M

-235.55%-2.72M

-15.27%-654.59K

-2.46%-466.55K

---638.59K

---811.82K

---567.86K

---455.36K

Net income from continuous operations

-746.02%-10.92M

-600.51%-7.73M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

-554.30%-4.28M

-555.02%-3.06M

-918.06%-6.50M

-235.55%-2.72M

-15.27%-654.59K

-2.46%-466.55K

---638.59K

---811.82K

---567.86K

---455.36K

Net income attributable to controlling interests

-940.65%-13.44M

-647.12%-8.24M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

-554.30%-4.28M

-555.02%-3.06M

-918.06%-6.50M

-235.55%-2.72M

-15.27%-654.59K

-2.46%-466.55K

---638.59K

---811.82K

---567.86K

---455.36K

Preferred share dividend

--2.51M

--514.11K

----

Net income attributable to common shareholders

-940.65%-13.44M

-647.12%-8.24M

-84.66%-2.28M

27.14%-1.05M

14.87%-1.29M

46.04%-1.10M

52.05%-1.24M

60.71%-1.44M

61.70%-1.52M

54.68%-2.04M

37.33%-2.58M

14.38%-3.67M

-29.59%-3.96M

30.61%-4.51M

-50.88%-4.11M

-554.30%-4.28M

-555.02%-3.06M

-918.06%-6.50M

-235.55%-2.72M

-15.27%-654.59K

-2.46%-466.55K

---638.59K

---811.82K

---567.86K

---455.36K

Basic earnings per share

-456.13%-9.32

-338.58%-6.28

-3075.76%-51.35

41.43%-1.15

18.97%-1.68

68.99%-1.43

53.97%-1.62

82.22%-1.96

82.59%-2.07

65.90%-4.62

71.52%-3.51

14.38%-11.01

-29.52%-11.88

19.01%-13.54

-41.86%-12.33

-515.22%-12.85

-516.17%-9.18

-720.14%-16.72

-235.54%-8.69

-15.27%-2.09

-2.46%-1.49

---2.04

---2.59

---1.81

---1.45

Diluted earnings per share

-404.13%-8.45

-338.58%-6.28

-3075.76%-51.35

41.43%-1.15

18.97%-1.68

68.99%-1.43

53.97%-1.62

82.22%-1.96

82.59%-2.07

65.90%-4.62

71.52%-3.51

14.38%-11.01

-29.52%-11.88

19.01%-13.54

-41.86%-12.33

-515.22%-12.85

-516.17%-9.18

-720.14%-16.72

-235.54%-8.69

-15.27%-2.09

-2.46%-1.49

---2.04

---2.59

---1.81

---1.45

Dividend per share

--0.00

Currency unit

USD

Audit opinions

--

Dogwood Therapeutics Inc

4.860USD

Dogwood Therapeutics Inc

4.860

Overview

Company

Financials

Statements

Income Statement

Balance Sheet

Cash Flow Statement